IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 277 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,910,000 | +45.5% | 48,172 | -3.1% | 0.07% | +28.8% |
| Q4 2018 | $2,687,000 | +3.3% | 49,707 | -1.4% | 0.05% | +13.0% |
| Q3 2018 | $2,600,000 | +23.9% | 50,411 | +0.1% | 0.05% | +12.2% |
| Q2 2018 | $2,098,000 | -6.3% | 50,336 | -0.9% | 0.04% | -10.9% |
| Q1 2018 | $2,239,000 | -12.0% | 50,785 | +0.4% | 0.05% | -13.2% |
| Q4 2017 | $2,543,000 | -1.5% | 50,559 | -0.7% | 0.05% | +3.9% |
| Q3 2017 | $2,582,000 | -0.4% | 50,929 | -0.1% | 0.05% | -13.6% |
| Q2 2017 | $2,592,000 | +26.4% | 50,957 | -0.1% | 0.06% | +18.0% |
| Q1 2017 | $2,050,000 | -18.1% | 51,012 | -2.6% | 0.05% | -12.3% |
| Q4 2016 | $2,503,000 | +117.3% | 52,373 | +66.2% | 0.06% | +96.6% |
| Q3 2016 | $1,152,000 | +57.2% | 31,514 | -0.1% | 0.03% | +31.8% |
| Q2 2016 | $733,000 | -47.2% | 31,556 | -8.1% | 0.02% | -48.8% |
| Q1 2016 | $1,389,000 | +36.4% | 34,352 | +108.4% | 0.04% | +30.3% |
| Q4 2015 | $1,018,000 | – | 16,480 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |